You are here: All Products  > Aslan Out-Licenses Korean Rights for Oncology Drug in $13 Million Deal

Aslan Out-Licenses Korean Rights for Oncology Drug in $13 Million Deal

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products